Free. Unsubscribe any time.
Mersana Therapeutics, Inc. (MRSN)
Mersana Therapeutics, Inc. filed 19 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 19 transactions and 82,172 shares. None carries the SEC's AFF10B5ONE flag; all 19 name a plan in a footnote. 4 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2025-10-28, came 43 days after the one before it (2025-09-15) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 77 shares, 1,935 fewer than the 2,012 in the filing before it.
- Its 19 plan statements rank 296th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 19 filings on file run from 2025-01-15 to 2025-10-28, and state 3 plan adoption dates, from 2023-05-10 to 2023-11-07.
Trades in Mersana Therapeutics, Inc. 19
- Bala Mohan — 2025-01-14 · S · 3,253 shares
- Carvajal Alejandra — 2025-01-14 · S · 3,330 shares
- DeSchuytner Brian — 2025-01-14 · S · 3,713 shares
- Lowinger Timothy B — 2025-01-14 · S · 3,483 shares
- Mandelia Ashish — 2025-01-14 · S · 1,007 shares
- Protopapas Anna — 2025-01-14 · S · 11,534 shares
- Carvajal Alejandra — 2025-01-15 · S · 952 shares
- DeSchuytner Brian — 2025-01-15 · S · 2,331 shares
- Lowinger Timothy B — 2025-01-15 · S · 1,794 shares
- Mandelia Ashish — 2025-01-15 · S · 1,791 shares
- Protopapas Anna — 2025-01-15 · S · 6,191 shares
- Bala Mohan — 2025-01-16 · S · 5,939 shares
Adoption dates in Mersana Therapeutics, Inc. 3
- 2023-05-10 — stated in 14 filings
- 2023-05-11 — stated in 3 filings
- 2023-11-07 — stated in 2 filings
Results prints in Mersana Therapeutics, Inc. 4
- 2025-03-03
- 2025-05-15
- 2025-08-13
- 2025-11-14
Trades before a print in Mersana Therapeutics, Inc. 0
- 18 days before the 2025-11-14 print — 2025-10-27 · S · Bala Mohan · 77 shares
- 46 days before the 2025-03-03 print — 2025-01-16 · S · Bala Mohan · 5,939 shares
- 46 days before the 2025-03-03 print — 2025-01-16 · S · Carvajal Alejandra · 5,096 shares
- 46 days before the 2025-03-03 print — 2025-01-16 · S · DeSchuytner Brian · 8,470 shares
- 46 days before the 2025-03-03 print — 2025-01-16 · S · Huber Martin H. Jr. · 4,514 shares
- 46 days before the 2025-03-03 print — 2025-01-16 · S · Lowinger Timothy B · 8,048 shares
- 46 days before the 2025-03-03 print — 2025-01-16 · S · Protopapas Anna · 8,637 shares
- 47 days before the 2025-03-03 print — 2025-01-15 · S · Carvajal Alejandra · 952 shares
- 47 days before the 2025-03-03 print — 2025-01-15 · S · DeSchuytner Brian · 2,331 shares
- 47 days before the 2025-03-03 print — 2025-01-15 · S · Lowinger Timothy B · 1,794 shares
- 47 days before the 2025-03-03 print — 2025-01-15 · S · Mandelia Ashish · 1,791 shares
- 47 days before the 2025-03-03 print — 2025-01-15 · S · Protopapas Anna · 6,191 shares
Interval to Mersana Therapeutics, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 18shortest, days
- 0no later print
Adoption dates Mersana Therapeutics, Inc. states
- 2023-05-10 in 14 filings
- 2023-05-11 in 3 filings
- 2023-11-07 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on May 10, 2023”
Reported results dates on file
- 2025-03-03
- 2025-05-15
- 2025-08-13
- 2025-11-14
A proxy statement is on file for this company in the same window (2025-04-29), which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.